v3.26.1
Business Segments - Schedule of Business Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Business Segment Information      
Net sales $ 6,030 $ 5,954  
Selling, general and administrative expenses 744 945  
Research, development and related expenses 308 285  
Operating income 1,397 1,246  
(Loss) gain on business divestitures (7) 0  
Total Corporate (4,633) (4,708)  
Other expense/(income), net 519 (139)  
Income before income taxes 878 1,385  
Depreciation and amortization 326 290  
Capital expenditures 225 236  
All other current assets 2,344   $ 2,823
Total assets 35,436   37,733
Operating Segments      
Business Segment Information      
Net sales 5,909 5,685  
Operating income 1,392 1,308  
Inventories 3,448   3,398
All other current assets 10,945   12,989
Total non-current assets 21,043   21,346
Operating Segments | Safety and Industrial      
Business Segment Information      
Net sales 2,930 2,745  
Cost of sales 1,571 1,470  
Selling, general and administrative expenses 452 451  
Research, development and related expenses 131 125  
Operating income 776 699  
Depreciation and amortization 144 139  
Capital expenditures 85 78  
Inventories 1,635   1,636
Operating Segments | Transportation and Electronics      
Business Segment Information      
Net sales 1,848 1,816  
Cost of sales 1,095 1,066  
Selling, general and administrative expenses 233 251  
Research, development and related expenses 121 109  
Operating income 399 390  
Depreciation and amortization 88 88  
Capital expenditures 58 78  
Inventories 1,072   1,068
Operating Segments | Consumer      
Business Segment Information      
Net sales 1,131 1,124  
Cost of sales 687 669  
Selling, general and administrative expenses 196 204  
Research, development and related expenses 31 32  
Operating income 217 219  
Depreciation and amortization 40 39  
Capital expenditures 11 11  
Inventories 741   $ 694
Corporate      
Business Segment Information      
Net sales 121 269  
Corporate-level (expense) income 34 50  
Net (costs) benefit from significant litigation 170 (74)  
(Loss) gain on business divestitures (7) 0  
Manufactured PFAS products (126) (38)  
Transformation costs (66) 0  
Total Corporate 5 (62)  
Depreciation and amortization 54 24  
Capital expenditures $ 71 $ 69